Hematopoietic stem cell transplantation for advanced myelodysplastic syndrome in children: Results of the EWOG-MDS 98 study

Leukemia

Volumn 25, Issue 3, 2011, Pages 455-462

  Strahm, B ^a   Nollke P ^a   Zecca, M ^b   Korthof, E T ^c   Bierings, M ^d   Furlan, I ^a   Sedlacek, P ^e   Chybicka, A ^f   Schmugge, M ^g   Bordon, V ^h   Peters, C ⁱ   O'Marcaigh, A ^j   De Heredia, C D ^k   Bergstraesser, E ^g   Moerloose, B D ^h   Van Den Heuvel Eibrink, M M ^l,m   Star, J ^e   Trebo, M ⁱ   Wojcik, D ^f   Niemeyer, C M ^a   Locatelli, F ⁿ   more..

^a UNIVERSITY OF FREIBURG   (Germany)

^b FONDAZIONE IRCCS POLICLINICO SAN MATTEO   (Italy)

^c LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^d UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^e UNIVERSITY HOSPITAL MOTOL   (Czech Republic)

^f WROCLAW MEDICAL UNIVERSITY   (Poland)

^g UNIVERSITY CHILDREN S HOSPITAL   (Switzerland)

^h GHENT UNIVERSITY HOSPITAL   (Belgium)

ⁱ ST ANNA CHILDREN S HOSPITAL   (Austria)

^j OUR LADY S CHILDREN S HOSPITAL   (Ireland)

^k HOSPITAL UNIVERSITARI VALL D HEBRON   (Spain)

^l ERASMUS MEDICAL CENTER   (Netherlands)

^m DUTCH CHILDHOOD ONCOLOGY GROUP   (Netherlands)

ⁿ UNIVERSITY OF PAVIA   (Italy)

more..

Author keywords

children; myelodysplastic syndrome; stem cell transplantation

Indexed keywords

ALEMTUZUMAB; BUSULFAN; CYCLOPHOSPHAMIDE; CYCLOSPORIN A; MELPHALAN; METHOTREXATE; THYMOCYTE ANTIBODY;

ACUTE GRAFT VERSUS HOST DISEASE; ACUTE GRANULOCYTIC LEUKEMIA; ADOLESCENT; ADULT; ARTICLE; BONE MARROW; CANCER MORTALITY; CANCER RELAPSE; CHILD; CHRONIC GRAFT VERSUS HOST DISEASE; CONTROLLED STUDY; FEMALE; FOLLOW UP; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HLA MATCHING; HUMAN; INCIDENCE; LIVING DONOR; MAJOR CLINICAL STUDY; MALE; MYELODYSPLASTIC SYNDROME; OVERALL SURVIVAL; PRIORITY JOURNAL; REFRACTORY ANEMIA WITH EXCESS BLASTS; REFRACTORY ANEMIA WITH EXCESS BLASTS IN TRANSFORMATION;

EID: 79952452293     PISSN: 08876924     EISSN: 14765551     Source Type: Journal    
DOI: 10.1038/leu.2010.297     Document Type: Article

References (29)

1. Niemeyer CM, Kratz CP. Paediatric myelodysplastic syndromes and juvenile myelomonocytic leukaemia: molecular classification and treatment options. Br J Haematol 2008; 140: 610-624. . (Pubitemid 351300914)
2. Hasle H, Wadsworth LD, Massing BG, McBride M, Schultz KR. A population-based study of childhood myelodysplastic syndrome in British Columbia, Canada. Br J Haematol 1999; 106: 1027-1032. . (Pubitemid 29463018)
3. Passmore SJ, Chessells JM, Kempski H, Hann IM, Brownbill PA, Stiller CA. Pediatric myelodysplastic syndromes and juvenile myelomonocytic leukaemia in the UK: a population-based study of incidence and survival. Br J Haematol 2003; 121: 758-767. . (Pubitemid 36718192)
4. Hasle H, Niemeyer CM, Chessells JM, Baumann I, Bennett JM, Kerndrup G et al. A pediatric approach to the WHO classification of myelodysplastic and myeloproliferative diseases. Leukemia 2003; 17: 277-282. . (Pubitemid 36266902)
5. Swerdlow SH, Campo E, Harris NL, Jaffe ES, Pileri SA, Stein H et al. WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues. IARC Press: Lyon, 2008. .
6. Sasaki H, Manabe A, Kojima S, Tsuchida M, Hayashi Y, Ikuta K et al. Myelodysplastic syndrome in childhood: a retrospective study of 189 patients in Japan. Leukemia 2001; 15: 1713-1720. . (Pubitemid 33061838)
7. Woods WG, Barnard DR, Alonzo TA, Buckley JD, Kobrinsky N, Arthur DC et al. Prospective study of 90 children requiring treatment for juvenile myelomonocytic leukemia or myelodysplastic syndrome: a report from the Children's Cancer Group. J Clin Oncol 2002; 20: 434-440. . (Pubitemid 34072526)
8. Locatelli F, Pession A, Bonetti F, Maserati E, Prete L, Pedrazzoli P et al. Busulfan, cyclophosphamide and melphalan as conditioning regimen for bone marrow transplantation in children with myelodysplastic syndromes. Leukemia 1994; 8: 844-849. . (Pubitemid 24161092)
9. Munoz A, de Heredia CD, Badell I, Bureo E, Gomez P, Martinez A et al. Allogeneic stem cell transplantation for myelodysplastic syndromes in children: a report from the Spanish Working Party for Blood and Marrow Transplantation in Children (GETMON). Pediatr Hematol Oncol 2009; 26: 345-355. .
10. Parikh SH, Mendizabal A, Martin PL, Prasad VK, Szabolcs P, Driscoll TA et al. Unrelated donor umbilical cord blood transplantation in pediatric myelodysplastic syndrome: a single-center experience. Biol Blood Marrow Transplant 2009; 15: 948-955. .
11. Yusuf U, Frangoul HA, Gooley TA, Woolfrey AE, Carpenter PA, Andrews RG et al. Allogeneic bone marrow transplantation in children with myelodysplastic syndrome or juvenile myelomonocytic leukemia: the Seattle experience. Bone Marrow Transplant 2004; 33: 805-814. . (Pubitemid 38519241)
12. Cantu RA, Fenu S, Kerndrup G, van Wering ER, Niemeyer CM, Baumann I. Evaluation of dysplastic features in myelodysplastic syndromes: experience from the morphology group of the European Working Group of MDS in Childhood (EWOG-MDS). Ann Hematol 2005; 84: 429-433. . (Pubitemid 40867918)
13. Glucksberg H, Storb R, Fefer A, Buckner CD, Neiman PE, Clift RA et al. Clinical manifestations of graft-versus-host disease in human recipients of marrow from HLA-matched sibling donors. Transplantation 1974; 18: 295-304. .
14. Przepiorka D, Weisdorf D, Martin P, Klingemann HG, Beatty P, Hows J et al. 1994 Consensus Conference on acute GVHD grading. Bone Marrow Transplant 1995; 15: 825-828. .
15. Storb R, Prentice RL, Sullivan KM, Shulman HM, Deeg HJ, Doney KC et al. Predictive factors in chronic graft-versus-host disease in patients with aplastic anemia treated by marrow transplantation from HLA-identical siblings. Ann Intern Med 1983; 98: 461-466. . (Pubitemid 13116613)
16. Kaplan E, Meier P. Nonparametric estimation from incomplete observations. J Am Stat Assoc 1958; 53: 456-481. .
17. Gooley TA, Leisenring W, Crowley J, Storer BE. Estimation of failure probabilities in the presence of competing risks: new representations of old estimators. Stat Med 1999; 18: 695-706. . (Pubitemid 29126745)
18. Klein JP, Rizzo JD, Zhang MJ, Keiding N. Statistical methods for the analysis and presentation of the results of bone marrow transplants. Part 2: Regression modeling. Bone Marrow Transplant 2001; 28: 1001-1011. . (Pubitemid 34030645)
19. Pepe MS, Longton G, Pettinger M, Mori M, Fisher LD, Storb R. Summarizing data on survival, relapse, and chronic graft-versushost disease after bone marrow transplantation: motivation for and description of new methods. Br J Haematol 1993; 83: 602-607. . (Pubitemid 23117438)
20. Cox D. Regression models and life tables (with discussion). J Royal Stat Soc B 1972; 34: 187. .
21. Kruskal WH, Wallis WA. Use of ranks in one-criterion variance analysis. J Am Stat Assoc 1952; 47: 583-621. .
22. Mann HB, Whitney DR. On a test of whether one or two random variables is stochastically larger than the other. Ann MathStat 1947; 18: 50-60. .
23. Trobaugh-Lotrario AD, Kletzel M, Quinones RR, McGavran L, Proytcheva MA, Hunger SP et al. Monosomy 7 associated with pediatric acute myeloid leukemia (AML) and myelodysplastic syndrome (MDS): successful management by allogeneic hematopoietic stem cell transplant (HSCT). Bone Marrow Transplant 2005; 35: 143-149. . (Pubitemid 40185929)
24. Woodard P, Barfield R, Hale G, Horwitz E, Leung W, Ribeiro R et al. Outcome of hematopoietic stem cell transplantation for pediatric patients with therapy-related acute myeloid leukemia or myelodysplastic syndrome. Pediatr Blood Cancer 2006; 47: 931-935. . (Pubitemid 44656117)
25. Pession A, Rizzari C, Putti MC, Masetti R, Casale F, Fagioli F et al. Results of the AIEOP AML 2002/01 study for treatment of children with acute myeloid leukemia. Blood (ASH Annu Meet Abstr) 2009; 114: 17. .
26. Zecca M, Masetti R, Balduzzi A, Fagioli F, Dini G, Messina C et al. Long-term outcome of children with acute myeloid leukemia in first remission given allogeneic HSCT from a matched family donor after a conditioning regimen comprising busulfan, cyclophosphamide and melphalan. Blood (ASH Annu Meet Abstr) 2009; 114: 2288. .
27. Chan GC, Wang WC, Raimondi SC, Behm FG, Krance RA, Chen G et al. Myelodysplastic syndrome in children: differentiation from acute myeloid leukemia with a low blast count. Leukemia 1997; 11: 206-211. . (Pubitemid 27085163)
28. Hasle H, Kerndrup G, Yssing M, Clausen N, Ostergaard E, Jacobsen N et al. Intensive chemotherapy in childhood myelodysplastic syndrome. A comparison with results in acute myeloid leukemia. Leukemia 1996; 10: 1269-1273. . (Pubitemid 26261421)
29. Webb DK, Harrison G, Stevens RF, Gibson BG, Hann IM, Wheatley K. Relationships between age at diagnosis, clinical features, and outcome of therapy in children treated in the Medical Research Council AML 10 and 12 trials for acute myeloid leukemia. Blood 2001; 98: 1714-1720.